News
24d
Pharmaceutical Technology on MSNFDA awards ODD status to Sanofi’s rilzabrutinib for two rare conditionsSanofi's reversible BTK inhibitor rilzabrutinib has gained the US Food and Drug Administration’s (FDA) orphan drug designation.
2mon
Everyday Health on MSNHow to Manage the Mental Health Effects of Immune ThrombocytopeniaYou can take steps to ensure you’re treating your whole body by following these suggestions: Living with immune thrombocytopenia can have a significant impact on your mental health and increase ...
Considering taking supplements to treat thrombocytopenia? Below is a list of common natural remedies used to treat or reduce the symptoms of thrombocytopenia. Follow the links to read common uses ...
Searching for effective treatment options for 'Thrombocytopenia symptom'? This page is a valuable resource, featuring a complete guide to the latest medications-both generic and branded-ideal for ...
Padeliporfin VTP (brand name Tookad) has previously been approved by the European Union, Israel, and Mexico as a treatment for low-risk prostate cancer, following demonstration of significant clinical ...
Hosted on MSN4mon
FDA accepts Sobi North America’s thrombocytopenia therapy sNDAThe US Food and Drug Administration (FDA) has accepted Sobi North America’s avatrombopag (DOPTELET) supplemental new drug application (sNDA) to treat paediatric immune thrombocytopenia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results